# Full Project Reassessment

## 1. Executive Summary

The repository is a substantial, well-documented engineering prototype for a synthetic breast-cancer monitoring workflow with a mature local FastAPI stack, RAG-oriented patient support flows, multi-agent-like safety routing, and extensive evaluation tooling. The strongest evidence is not in a production deployment; it is in the breadth of local engineering scaffolding, introspection, and synthetic-data safety/evaluation machinery.

The current project is best described as a highly engineered synthetic engineering prototype with real product intent but incomplete operational proof. It is not yet a safe or credible deployment target for authenticated real-user access, PHI handling, or medical decision support.

The main issue is not a lack of modules. The issue is that most of the high-value components are either: (a) locally integrated but not proven in production conditions, (b) evaluation-only rather than runtime-integrated, or (c) safety/evaluation scaffolding that adds complexity without removing the dominant operational blockers. The DEP-001 work is a good example: it increased observability and determinism, but it has not yet produced independent, externally valid proof of generalization and it is currently competing with more urgent deployment blockers such as authentication, tenant isolation, privacy boundaries, and operational recovery.

The repository does have credible signs of engineering maturity in a few places:

- A real FastAPI backend with role-scoped access patterns in [backend/api/main.py](backend/api/main.py), [backend/api/deps.py](backend/api/deps.py), and [backend/services/auth.py](backend/services/auth.py)
- A visible safety-routing and RAG orchestration architecture in [backend/services/agent_rag.py](backend/services/agent_rag.py) and [backend/services/agent_safety.py](backend/services/agent_safety.py)
- A Docker local deployment path in [docker-compose.yml](docker-compose.yml) and [docker-compose.prod.yml](docker-compose.prod.yml)
- CI/CD and release-gate artifacts in [.github/workflows/ci.yml](.github/workflows/ci.yml) and [.github/workflows/ship.yml](.github/workflows/ship.yml)
- A clear policy and architecture narrative in [README.md](README.md)

The key gap is that these elements are not yet tied to evidence that would justify any medical-AI deployment. The project is still better classified as a controlled synthetic demo / local prototype with serious governance and deployment work still outstanding.

## 2. Architecture Map

### User-facing flows

- Patient portal and clinician/admin experience are served through the FastAPI app and static frontend assets, with redirects from [/backend/api/main.py](backend/api/main.py) to /frontend routes.
- Auth flows use demo sessions and optional OIDC hooks via [backend/services/auth.py](backend/services/auth.py) and [backend/services/oidc_auth.py](backend/services/oidc_auth.py).
- Patient data and clinician review flows are modeled in [backend/models.py](backend/models.py) and successively routed through patient and clinician APIs.

### Agent orchestration

- The runtime orchestrator is centered on [backend/services/agent_rag.py](backend/services/agent_rag.py).
- Safety classification, intent routing, input/output guardrails, retrieval, caching, and post-generation validation are split across dedicated modules but still re-exported through this shim.

### RAG pipeline

- Retrieval and filtering flow through [backend/services/agent_retrieval.py](backend/services/agent_retrieval.py), [backend/services/agent_kb_corpus.py](backend/services/agent_kb_corpus.py), [backend/services/rag_vector_index.py](backend/services/rag_vector_index.py), and [backend/services/managed_vector_store.py](backend/services/managed_vector_store.py).
- Safety-aware RAG enforcement is layered in [backend/services/agent_safety.py](backend/services/agent_safety.py) and related validation modules.
- Release and evidence gating is tracked through multiple report artifacts under [Data/evals](Data/evals) and release-gate files in [config/release_gate_thresholds.yaml](config/release_gate_thresholds.yaml).

### Evidence validation and generation

- Evidence envelope and claim validation are present in the RAG modules under [backend/services](backend/services).
- Generation is not a single monolith; it is split across answer composition, post-generation validation, and evidence enforcement.
- The implementation is more disciplined than many prototypes, but it still lacks system-wide production proof.

### Safety routing and patient-context handling

- Safety scopes and routing decisions are implemented in [backend/services/agent_safety.py](backend/services/agent_safety.py).
- Patient scope is enforced during auth and access checks in [backend/services/auth.py](backend/services/auth.py), [backend/api/deps.py](backend/api/deps.py), and [backend/models.py](backend/models.py).
- This is a synthetic sandbox, not a proven patient-care authorization model.

### Multimodal / temporal ML components

- The repository contains serious synthetic ML governance work in the backend services and evaluation scripts.
- The README clearly states that this is synthetic-only and not clinically validated.
- Temporal, patient-journey, and synthetic modeling are present but form an engineering environment rather than a production clinical system.

### API / backend / frontend

- Backend: [backend/api/main.py](backend/api/main.py), routers under [backend/api/routers](backend/api/routers)
- Data model: [backend/models.py](backend/models.py)
- DB: [backend/database.py](backend/database.py)
- Frontend: [frontend](frontend) and [frontend-react](frontend-react)

### Authentication / Authorization / Storage / Database / Caching / Workers

- Authentication and demo sessions: [backend/services/auth.py](backend/services/auth.py), [backend/services/oidc_auth.py](backend/services/oidc_auth.py)
- Role enforcement: [backend/api/deps.py](backend/api/deps.py)
- Database: [backend/database.py](backend/database.py)
- Caching: [backend/services/agent_cache.py](backend/services/agent_cache.py), [backend/services/rag_cache.py](backend/services/rag_cache.py)
- Queue / worker patterns: [backend/services/saas_job_worker.py](backend/services/saas_job_worker.py), [backend/services/background_eval_worker.py](backend/services/background_eval_worker.py)
- Redis: [docker-compose.yml](docker-compose.yml)

### Deployment scripts and containerization

- Docker and Compose files exist in [Dockerfile](Dockerfile), [docker-compose.yml](docker-compose.yml), [docker-compose.prod.yml](docker-compose.prod.yml), and recovery smoke files.
- Deployment readiness checks are in [backend/services/deployment_readiness.py](backend/services/deployment_readiness.py).

### CI/CD / observability / evaluation infrastructure / release gates

- CI and ship workflows: [.github/workflows/ci.yml](.github/workflows/ci.yml), [.github/workflows/ship.yml](.github/workflows/ship.yml)
- Release gate: [config/release_gate_thresholds.yaml](config/release_gate_thresholds.yaml)
- Governance and evidence summaries: [Data/evals/governance/latest_focused_release_summary.json](Data/evals/governance/latest_focused_release_summary.json)

### Classification of components

Production-integrated:
- FastAPI app structure
- Auth session logic and role checks
- Core patient and clinician routes
- Local DB and patient context model
- Dockerized local runtime
- CI workflow and release checks

Partially integrated:
- OIDC support and browser PKCE scaffolding
- Tenant-aware SaaS control plane
- Managed vector store scaffolding
- Worker/job orchestration helpers
- Kb/vector retrieval runtime wrappers

Evaluation-only:
- DEP-001 blind bank and frozen candidate infrastructure
- many benchmark and adversarial eval scripts under [backend/services](backend/services)
- synthetic holdout, external stress, and evaluation artifacts under [Data/evals](Data/evals)

Development-only:
- demo auth, demo patient listing, synthetic-only routes
- demos and local synthetic staging assets

Legacy:
- multiple older safety and routing modules that preserve compatibility but are no longer the canonical path

Dead/unreferenced:
- some duplicate modules and older evaluation scaffolds are likely left behind by the many safety phases; the codebase contains several partially duplicated safety paths

Duplicated:
- multiple DEP-001-era safety modules and rerun artifacts appear to overlap conceptually

Experimental:
- managed vector shadow sync, optional Azure/Pinecone patterns, sandboxed multi-tenant control plane, and several safety generalization layers

### DEP-001-specific assessment

The DEP-001 work increased architecture complexity and reading of evidence, but it mostly improved the evaluation harness and safety-process discipline rather than the actual production path. The core issue is that it is still fundamentally a benchmark / governance exercise, not a validated deployment control.

## 3. Current Maturity

The project is a controlled synthetic engineering prototype with a significant level of internal tooling maturity, but not with product-grade deployment maturity. It has more evidence than a typical demo, but far less than a real healthcare deployment.

A rough current maturity profile:

- Strong internal engineering scaffolding: yes
- Real deployment evidence: no
- Authentication and tenant isolation proof: weak
- Medical safety proof: weak
- Privacy controls: partial and insufficient
- Operational recovery and incident response: weak
- Production reliability: not demonstrated

## 4. Domain Scores

| Area | Score | Summary |
|---|---:|---|
| AI Engineering | 7.5 | Architectural breadth and safety orchestration are strong, but proof remains synthetic-only. |
| RAG / Agent Architecture | 6.5 | Good routing and evidence envelope design, but not proven under production conditions. |
| ML / MLE | 6.0 | Synthetic model governance is strong, but clinical and real-world validity are absent. |
| Software Engineering | 7.0 | Structure is thoughtful and modular, but complexity is accumulating. |
| Backend/API | 7.0 | FastAPI and routes are real and coherent. |
| Data Engineering | 6.5 | Data contracts and governance are present, but no operational PHI-grade data lifecycle. |
| Evaluation Science | 7.5 | Broad eval infrastructure is a real strength. |
| Medical Safety | 4.5 | Some policy boundaries exist but independent clinical safety proof is absent. |
| Security | 4.0 | Security posture is better than a basic demo, but not production-grade. |
| Privacy | 4.5 | Synthetic handling is explicit, but PHI governance and retention lifecycle are not proven. |
| Authentication | 3.5 | Demo auth exists; OIDC is feature-flagged and not proven in a real deployment. |
| Authorization / Tenant Isolation | 4.0 | Some tenant-scoping exists, but not a live multi-user closed-beta proof. |
| Reliability | 4.5 | Local fail-closed patterns are present, but operational failure behavior is not fully proven. |
| Observability | 5.5 | Metrics and logging exist, but not enough for a real incident workflow. |
| MLOps | 6.0 | Training/eval/registry artifacts exist, but not full production lifecycle proof. |
| DevOps / CI-CD | 6.5 | CI/CD is strong by prototype standards. |
| Infrastructure | 5.5 | Container scaffolding and Azure ideas exist, but live deployment evidence is absent. |
| Scalability | 5.0 | Structure is explainable but not proven at real load. |
| Testing | 6.0 | Solid suite, but not enough proof of correctness under production-like failure. |
| Deployment Readiness | 3.5 | Containerization exists, but not credible staged deployment readiness. |
| Documentation | 8.0 | This is one of the strongest parts of the repository. |
| Governance | 7.0 | Governance is impressive on paper, but still synthetic and not externally audited. |
| Maintainability | 6.0 | The repo is modular but increasingly complex. |
| Cost Efficiency | 5.0 | Some cost telemetry exists, but it is still planning-level rather than operational truth. |
| Product / UX Safety | 6.5 | Strong boundaries are built in, but not enough real-user evidence. |

### Strongest evidence

- Real backend + routing + static frontend path in [backend/api/main.py](backend/api/main.py)
- Safety and RAG architecture in [backend/services/agent_rag.py](backend/services/agent_rag.py) and [backend/services/agent_safety.py](backend/services/agent_safety.py)
- Evaluation scaffolding and release-gate infrastructure in [config/release_gate_thresholds.yaml](config/release_gate_thresholds.yaml)
- Documentation quality in [README.md](README.md)

### Weakest evidence

- Auth/tenant isolation not proven in real multi-user deployment
- OIDC and PKCE are not complete live-provider proofs
- PHI/privacy lifecycle and retention are not demonstrated
- Deployment rollback and recovery evidence is local-only
- External, independent medical safety validation is absent

### Implementation vs proof

This repository is richer in implementation than in proof. It can describe a strong architecture, but it cannot yet show a credible operationally safe deployment path.

## 5. Critical Findings

### CF-01 — Security and deployment readiness remain materially incomplete

- Domain: Security / Deployment / Authentication
- Severity: Critical
- Problem: The repository says demo auth is intended for development only, but the actual production path and non-demo identity controls are not demonstrated against a real provider. OIDC is feature-flagged and not validated in a real environment.
- Evidence: [backend/services/auth.py](backend/services/auth.py), [backend/services/oidc_auth.py](backend/services/oidc_auth.py), [backend/services/deployment_readiness.py](backend/services/deployment_readiness.py)
- Failure scenario: A staged or production deployment without a real identity provider and strict session controls could mis-assign access or expose data.
- Likelihood: Medium
- Impact: High
- Blocks deployment: Yes
- Remediation: Require a verified IdP, strict JWT validation, environment-specific auth policy, and explicit staging/prod gating.
- Required evidence: OIDC token issuance test, token exchange test, session rotation, edge-case JWT rejection tests.

### CF-02 — Authorization and tenant isolation are not yet proven for multi-user use

- Domain: Authorization / Tenant Isolation
- Severity: Critical
- Problem: The code contains tenant-scoping scaffolding, but the project does not yet provide real proof that a real multi-user deployment is safe.
- Evidence: [backend/services/tenant_scoping.py](backend/services/tenant_scoping.py), [backend/services/saas_control_plane.py](backend/services/saas_control_plane.py), [backend/models.py](backend/models.py)
- Failure scenario: Cross-user leakage or object-level access failures under concurrent or seeded data.
- Likelihood: Medium
- Impact: High
- Blocks deployment: Yes
- Remediation: Add real multi-tenant access tests, row-level authorization, and environment-specific isolation assertions.
- Required evidence: multi-user tenant isolation tests and object-level access checks.

### CF-03 — Privacy lifecycle and PHI handling are not demonstrated

- Domain: Privacy
- Severity: Critical
- Problem: The project is explicit that it is synthetic-only, but the real deployment path still lacks a complete retention, deletion, audit, and PHI-handling model.
- Evidence: [README.md](README.md), [backend/models.py](backend/models.py), [backend/services/saas_control_plane.py](backend/services/saas_control_plane.py)
- Failure scenario: A deployment accidentally processes real patient data without the required lifecycle, retention, or deletion policy.
- Likelihood: Medium
- Impact: High
- Blocks deployment: Yes
- Remediation: Define approved PHI policy and retention/deletion controls before any real-user deployment.
- Required evidence: privacy review, retention schedule, deletion tests, audit log verification.

### CF-04 — The repository’s safety architecture is overbuilt relative to its deployment proof

- Domain: Architecture Complexity / Medical Safety
- Severity: Critical
- Problem: There are many safety and evaluation modules, but the architecture is not yet simplified into a proven production path.
- Evidence: [backend/services](backend/services), [Data/evals](Data/evals), [artifacts](artifacts)
- Failure scenario: Operational complexity causes silent policy drift, uncertainty, or inconsistent safety behavior.
- Likelihood: High
- Impact: High
- Blocks deployment: Yes
- Remediation: Freeze the current experiment-heavy safety path, reduce the number of active runtime paths, and preserve a single authoritative safety mechanism.
- Required evidence: a single authoritative runtime path plus route and fault-injection tests.

### CF-05 — DEP-001 remains a benchmark governance problem, not deployment evidence

- Domain: Medical Safety / Evaluation Science
- Severity: Critical
- Problem: DEP-001 has produced lots of evidence and governance artifacts, but no external blind proof and no clinical deployment proof.
- Evidence: [config/release_gate_thresholds.yaml](config/release_gate_thresholds.yaml), [README.md](README.md), [Data/evals/governance/latest_focused_release_summary.json](Data/evals/governance/latest_focused_release_summary.json)
- Failure scenario: The project continues to invest in another safety loop without proving real improvement.
- Likelihood: High
- Impact: High
- Blocks deployment: Yes
- Remediation: Pause another DEP-001 evaluation cycle until auth, tenancy, and privacy blockers are addressed.
- Required evidence: external holdout or external review, not more internal metrics.

## 6. High Findings

### HF-01 — Real deployment reliability and recovery are not proven

- Domain: Reliability
- Severity: High
- Evidence: [backend/services/container_recovery_smoke.py](backend/services/container_recovery_smoke.py), [docker-compose.recovery-smoke.yml](docker-compose.recovery-smoke.yml), local Docker checks
- Problem: Recovery and failure behaviors are mostly smoke tests, not production recovery drills.

### HF-02 — Observability is present but not yet sufficient for operator diagnosis

- Domain: Observability
- Severity: High
- Evidence: request ID and telemetry surfaces in [backend/api/main.py](backend/api/main.py), but strong incident workflows and alerting are not demonstrated.

### HF-03 — Safety and routing logic may be too broad and not yet a single source of truth

- Domain: Architecture Complexity / RAG Safety
- Severity: High
- Evidence: many modules under [backend/services](backend/services)

### HF-04 — Deployment readiness is explicitly engineering-only and still not healthcare deployment-ready

- Domain: Deployment Readiness
- Severity: High
- Evidence: [backend/services/deployment_readiness.py](backend/services/deployment_readiness.py)

### HF-05 — Some key evidence is synthetically constrained and may not generalize

- Domain: ML / Evaluation Science
- Severity: High
- Evidence: [README.md](README.md), [Data/evals/governance/latest_focused_release_summary.json](Data/evals/governance/latest_focused_release_summary.json)

### HF-06 — Current auth posture is too permissive for real user deployments

- Domain: Authentication / Security
- Severity: High
- Evidence: [backend/services/auth.py](backend/services/auth.py)

### HF-07 — No real-user or real-data closed-beta milestone is demonstrated

- Domain: Product / Deployment
- Severity: High
- Evidence: readiness docs and README explicitly note that external review and real patient validation are missing.

### HF-08 — Production-grade backups and restore controls are still not evidenced

- Domain: Infrastructure / Reliability
- Severity: High
- Evidence: Compose files and readiness docs, plus the repo statement that managed cloud restore and external validation remain unproven.

## 7. Medium Findings

### MF-01 — The project still mixes synthetic demo behavior with production-shaped semantics.

### MF-02 — The number of safety/evaluation artifacts may be creating benchmark overfitting risk.

### MF-03 — Cost telemetry is still mostly engineering estimates rather than real operational truth.

### MF-04 — Some operational boundaries are documented but not enforced by strong end-to-end tests.

### MF-05 — The frontend and backend are decently connected, but the user-facing deployment story remains broader than the runtime evidence.

## 8. Low Findings

### LF-01 — Some docs are strong but may overstate the system’s current state without enough operational evidence.

### LF-02 — A few modules appear to act as compatibility shims, indicating architecture drift.

## 9. DEP-001 Assessment

The project has generated substantial internal safety-evaluation work, but it has not yet produced the evidence that should justify a move to the next stage of deployment. The key result is not that the project is failing; it is that DEP-001 has become a large internal benchmark process that is now reducing the marginal value of engineering time.

What DEP-001 has proven:
- The repo can build a deterministic safety-routing and fail-closed system around local synthetic cases.
- The architecture can include governance artifacts and explicit red lines.
- A large set of synthetic adversarial and routing evaluation artifacts can be produced.

What DEP-001 has not proven:
- Generalization to independent external no-read holdouts.
- Real deployment safety.
- Real cross-user tenant safety.
- Medical correctness and real-world value.
- A stable production path that would merit continued complexity.

Recommendation: B — Freeze current DEP-001 work temporarily and address another blocker.

The immediate next blocker is not another safety loop; it is a credible deployment foundation: auth, tenant isolation, privacy lifecycle, and operational controls.

## 10. Security / Privacy

The project is not currently safe for a real authenticated multi-user deployment.

The current authentication posture is primarily demo-session based, with optional OIDC scaffolding. That is not the same as real and operationally safe authentication. The project uses explicit boundaries to avoid obvious risk, but there is still a large gap between the code’s intended posture and real-world safety.

The strongest security signals are:
- explicit environment gates for demo auth
- CORS restrictions and default security headers
- an explicit fail-closed design in several safety modules
- synthetic-only product boundaries

The weakest security/privacy signals are:
- live OIDC validation not yet shown against a real provider
- no full authenticated multi-user tenant proof
- no PHI/PII retention and deletion control evidence
- no recovery / incident response evidence

## 11. Reliability

Important dependency handling exists in a partly structured way, but the reliability story is incomplete. For local operations, fail-closed logic is present. For real deployment, the repo still lacks end-to-end proof for major dependency failures, including vector store unavailability, DB outages, cache corruption, queue backlogs, and failed rollbacks.

The project should not claim a controlled deployment until those fail scenarios have explicit tests and operator workflows.

## 12. Observability

The repo has request IDs, telemetry hooks, safety metrics, and operational artifacts; this is materially better than a basic app. However, it is still not a production incident-ops stack. There is not enough evidence that an operator could diagnose cross-service failures quickly or trace incidents from user request to model retrieval to downstream output.

The missing piece is a fully integrated incident workflow with reliable metrics, traces, alerts, and dashboards tied to real deployment state.

## 13. ML / MLOps

The project has a rich synthetic ML and eval stack, including model artifacts, governance, training comparisons, and release-gate logic. This is one of the repo’s stronger categories.

However, the project does not have proof that bad or mismatched models cannot reach runtime, and it does not have real-world production promotion evidence. It is a sophisticated research/engineering sandbox, not a validated production MLOps system.

## 14. RAG / Agent

The RAG and agent design is among the most impressive parts of the repository. The architecture is well reasoned, with route policies, retrieval filtering, evidence gates, and a clear separation of responsibilities.

The problem is not that the RAG system is absent; it is that the observational evidence is not yet strong enough to justify clinical deployment. The repository is still strongest in engine design and weakest in external validation.

## 15. Test Quality

The project has a larger-than-average set of unit, integration, safety, and synthetic eval tests. This is valuable. But the tests are still largely proving the implementation, not full deployment correctness. There are many tests that show the system works under intended synthetic scenarios, but not yet that it is reliable under authentic multi-user, multi-tenant, or production-style failure conditions.

The repo is not weak on testing volume; it is weak on the quality of production-like proof.

## 16. Architecture Complexity

The project has accumulated a large number of safety, evaluation, and governance modules. This makes it richer and more credible as a research platform, but it also exposes the project to drift, overfitting, and complexity risk.

The strongest recommendation is to maintain only one authoritative runtime safety and storage path, and to retire or archive secondary safety or evaluation flows after they have been audited.

## 17. Deployment Stage Assessment

### Stage 0 — local synthetic developer demo
- READY: Yes

### Stage 1 — containerized local deployment
- READY: Yes, with caveats
- Blockers: local auth posture, environment proof, failure-mode checks

### Stage 2 — private staging environment
- NOT READY
- Blockers: auth, tenant isolation, privacy lifecycle, real container ops evidence, backups, monitoring

### Stage 3 — authenticated closed beta with synthetic/non-PHI data
- NOT READY
- Blockers: no verified auth, no tenant isolation proof, no real recovery tests, no production incident workflow

### Stage 4 — limited educational production deployment
- NOT READY

### Stage 5 — broader production deployment
- NOT READY

Earliest defensible deployment stage: Stage 1 (containerized local deployment), but only as a constrained local engineering deployment and not as a patient-facing production service.

## 18. Recommended Deployment Architecture

### A. Minimum viable private staging architecture

- Frontend: React app served behind a local reverse proxy or static host
- Backend API: FastAPI app behind TLS termination
- Database: Postgres in a private network with backups and consistent schema migration
- Vector store: local FAISS or explicit managed index in an isolated non-PHI sandbox; no live patient data
- Model/inference: deterministic and local-only inference, no hidden model-serving cluster
- Background worker: local worker process with queue and bounded retry pattern
- Cache: Redis with explicit cache-key isolation and no co-mingled tenant data
- Auth: verified IdP/OIDC against a staging issuer; no demo auth in staging
- Secrets: managed environment secrets, not repo files
- TLS: enforced by reverse proxy
- Load balancer: simple reverse proxy or single instance with health checks
- Object storage: optional, only if used for non-PHI artifacts
- Monitoring: logs + request IDs + minimal metrics
- CI/CD: single pipeline for container build, tests, smoke checks, and schema validation
- Backups: regular snapshot and restore test
- Rollback: image tag + DB migration strategy and revert path

### B. Closed-beta architecture

- Same as above, but with strict identity provider, real tenant isolation, auditable access logs, safe object storage, and incident response practice.

### C. Components that should NOT be introduced yet

- Kubernetes as a default platform
- microservice decomposition
- a dedicated service mesh
- custom model serving cluster
- broad multimodal expansion
- more feature breadth beyond the core patient monitoring workflow

## 19. Top 10 Next Engineering Actions

1. Establish a real production-grade identity and session model for staging/prod.
2. Harden tenant isolation and row-level authorization for all patient resources.
3. Define and test privacy lifecycle controls for retention, deletion, and auditability.
4. Simplify the runtime safety path to one authoritative implementation.
5. Remove or archive redundant DEP-001-era safety modules and frozen candidate paths.
6. Add production-like failure tests for DB, cache, queue, vector store, and rollback conditions.
7. Implement real operational observability for incident triage and alerting.
8. Run a realistic staged recovery and backup drill with documented rollback path.
9. Freeze the evaluation harness from runtime use and enforce a clear separation between experiment and deployment code.
10. Build explicit closed-beta acceptance criteria around auth, access, privacy, and incident handling.

## 20. 30/60/90 Day Roadmap

### 30-day roadmap

- Task: Real auth and session hardening
- Owner role: backend/security engineer
- Prerequisite: environment inventory and IdP selection
- Deliverable: staging-only real auth path
- Acceptance gate: token validation and session tests pass

- Task: tenant isolation test suite
- Owner role: backend engineer
- Prerequisite: auth model
- Deliverable: enforced access matrix
- Acceptance gate: cross-tenant access denied, patient records isolated

- Task: privacy lifecycle policy draft
- Owner role: security/privacy lead
- Prerequisite: approved data classification
- Deliverable: retention/deletion plan
- Acceptance gate: review and test artifacts approved

### 60-day roadmap

- Task: private staging deployment
- Owner role: devops + backend engineer
- Prerequisite: auth + privacy + isolation
- Deliverable: working private staging environment
- Acceptance gate: smoke tests and incident triage passes

- Task: backup/restore drill
- Owner role: infra engineer
- Prerequisite: valid private staging config
- Deliverable: successful restore workflow
- Acceptance gate: restore test passes

### 90-day roadmap

- Task: authenticated closed beta with synthetic/non-PHI data
- Owner role: product + engineering lead
- Prerequisite: staging is stable and secure
- Deliverable: beta environment and access policy
- Acceptance gate: access, monitoring, incident, and failover controls proven

## 21. Stop / Start / Continue

### STOP
- Endless benchmark and safety-bank churn without an external holdout
- Adding more safety modules without reducing the runtime path
- Treating synthetic metrics as deployment evidence
- More deployment scaffolding without real auth, privacy, and recovery controls

### START
- Verified IdP-based auth in staging
- Row-level tenant authorization tests
- Clear privacy and deletion lifecycle workflows
- Recovery and rollback drills
- Operator diagnostics with alerting and traces

### CONTINUE
- Strong evaluation discipline
- Safety boundary checks
- Documentation practices
- Local environment and Docker automation

## 22. What Not To Build

- Kubernetes as a first move
- microservice decomposition
- service-mesh complexity
- custom model serving cluster
- large multimodal expansion
- extra product feature breadth beyond the core workflow

These are not needed before the project proves the core deployment path: auth, privacy, tenant isolation, reliability, and incident handling.

## 23. Portfolio Assessment

### Impressive parts

- Strong engineering architecture and documentation
- Real FastAPI app
- Clear safety and RAG boundaries
- Broad eval and governance infrastructure
- Good artifact and evidence discipline

### Overbuilt parts

- DEP-001-era complexity and duplicated safety work
- numerous parallel evaluation and governance layers
- several security and privacy controls that are documented but not yet proven in real environments

### Questions interviewers would likely ask

- What has been proven in production-like conditions?
- What is the single runtime truth for safety and access control?
- What external evidence prevents the project from being a sandbox?
- Which deployment stages are actually supported by evidence?

### Best evidence to improve credibility

- Real staging auth and tenant isolation evidence
- recovery/rollback and backup drill results
- a closed-beta acceptance report with security and privacy proof
- operational incident playbooks

### Best 3 demos for maturity proof

1. End-to-end local staging deployment with authentication and tenant isolation
2. Recovery and rollback drill with queue/cache/DB failure cases
3. Safety+access incident and observability demo showing full traceability

## 24. Final Recommendation

The repository is not ready for extensive deployment beyond local engineering use. It is already far beyond a toy demo, but it has not reached a credible controlled deployment level. The best immediate move is to freeze the intricate DEP-001 loop, simplify the runtime architecture, and focus engineering effort on authentication, authorization, privacy lifecycle, recovery, and staged operational proof. The project should remain a controlled synthetic engineering prototype until these controls are demonstrably in place.

## 25. Score Summary

- Portfolio quality score: 7.0/10
- Engineering maturity score: 6.2/10
- Production readiness score: 3.3/10
- Medical-AI deployment readiness score: 2.5/10
- Risk-weighted overall score: 3.8/10

## 26. Final verdict

The strongest conclusion is: this is a rich, thoughtful, and well-documented synthetic engineering implementation with very real architecture and evaluation quality, but not enough operational proof to justify medical deployment or anything beyond a tightly controlled local prototype.
